Overview
Table of Contents
Tables and Figures
Survey Questions
Executive Summary
Download Report Brochure
Download Sample Pages
Length 166 pages
Date published January 2007
Additional info Single-site, country, and global licenses are multi-user, searchable, and cut-and-paste ready PDFs delivered by e-mail.
Corporate subscriptions:Contact David Cunningham,Global Report Sales781-972-5472
Questions and to order by phone:Contact Rose LaRaiaCustomer Service781-972-5444
Ken Rubenstein, PhD
Biomarkers Survey Questions1. Please classify your organization.2. Please identify your position.3. In which stage(s) of work are you involved?4. In what area(s) of research are you involved?5. At what level(s) is your organization involved with biomarker planning and discovery?6. Please choose 1 or more of the options that apply to your organization:Supports precommercial, collaborative biomarker development/validationDoes not support precommercial, collaborative biomarker development/validationExpects to be a member of the NIH/FDA/PhRMA Biomarkers ConsortiumDoes not expect to be a member7. What is your organization’s view toward SOPs or guidelines for biomarker development?8. What is your organization’s position on outsourcing biomarker discovery and development?9. If your organization does any biomarker outsourcing, why? (multiple answers OK)10. What type(s) of biomarkers does your organization use?11. In what stage(s) does your organization use biomarkers?12. What are the plans for your organization’s budget for biomarker-related work for fiscal 2007?13. What are the plans for your organization’s budget for biomarker-related work for the next 3 years?